Beacon Capital Management LLC (Tennessee)’s CRISPR Therapeutics CRSP Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $13K | Buy |
268
+111
| +71% | +$5.4K | ﹤0.01% | 580 |
|
|
2025
Q1 | $5.34K | Buy |
157
+89
| +131% | +$3.03K | ﹤0.01% | 756 |
|
|
2024
Q4 | $2.68K | Buy |
+68
| New | +$2.68K | ﹤0.01% | 831 |
|
|
2022
Q4 | – | Sell |
-50
| Closed | -$3K | – | 1002 |
|
|
2022
Q3 | $3K | Hold |
50
| – | – | ﹤0.01% | 666 |
|
|
2022
Q2 | $3K | Hold |
50
| – | – | ﹤0.01% | 706 |
|
|
2022
Q1 | $3K | Buy |
+50
| New | +$3K | ﹤0.01% | 707 |
|